Psychemedics Corp (NASDAQ:PMD)

20.23
Delayed Data
As of 9:30am ET
 -0.0989 / -0.49%
Today’s Change
15.99
Today|||52-Week Range
27.99
-1.61%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Services to the Health Industry
MARKET CAP
$110.8M

Company Description

Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. Its testing methods utilize a technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The company performs custom-designed enzyme immunoassay on the liquid supernatant, with confirmation testing by mass spectrometry. It provides screening and confirmation by mass spectrometry for cocaine; marijuana; phencyclidine; amphetamines including ecstasy; and opiates such as including heroin, hydrocodone, hydromorphone, oxycodone and codeine. Psychemedics was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Acton, MA.

Contact Information

Psychemedics Corp.
289 Great Road
Acton Massachusetts 01720
P:(978) 206-8220
Investor Relations:

Employees

Shareholders

Other institutional42.03%
Individual stakeholders18.61%
Mutual fund holders13.96%

Top Executives

Raymond C. KubackiChairman, President & Chief Executive Officer
Neil L. LernerTreasurer & Vice President-Finance
James AbelyVice President & General Counsel
Michael I. SchafferVice President-Laboratory Operations
Charles M. DoucotVice President-Sales & Marketing